source
- Cardio firms including AstraZeneca and Novartis to showcase heart drug data at ESC 2026At the European Society of Cardiology's annual meeting in 2026, several pharmaceutical companies will present cardiovascular data. The lineup includes AstraZeneca, Ionis, Cytokinetics, Novartis an…
- Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanismRoche has taken its obesity strategy into uncharted territory via a $190 million upfront payment for a clinical-stage urocortin-2 analog from South Korea’s Hanmi Pharm.Fierce Biotech · 12h ago↗ source
- Scribe Therapeutics’ early-stage IPO surges 43% as epigenetic cholesterol drug enters clinic